Repetitive transcranial magnetic stimulation for treatment-resistant depression: OHTAC recommendation
Health Quality Ontario
Record ID 32016000560
English
Authors' recommendations:
OHTAC recognizes that electroconvulsive therapy (ECT) is the most effective treatment for non-psychotic, treatment-resistant depression. OHTAC therefore recommends that repetitive transcranial magnetic stimulation be publicly funded for patients with nonpsychotic, treatment-resistant depression only when ECT is not an option.
Health Quality Ontario conducted a review to determine the clinical effectiveness of rTMS compared to either electroconvulsive therapy or sham treatment. In addition, Health Quality Ontario worked with the Programs for Assessment of Technology in Health (PATH) Research Institute to evaluate cost-effectiveness and one-year budgetary impact of the technology.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hqontario.ca/Portals/0/documents/eds/ohtas/recommendation-rtms-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Depression
- Depressive Disorder, Treatment-Resistant
- Transcranial Magnetic Stimulation
- Treatment Outcome
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.